{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:12:22Z","timestamp":1790662342829,"version":"4.1.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Myeloproliferative neoplasms (MPN) are associated with a high symptom burden and impaired quality of life (QoL), often unaided by available treatments. Physical activity has demonstrated benefits in other cancers; however, its potential has yet to be explored in MPN. This randomized controlled trial aimed to evaluate the feasibility, acceptability, and efficacy of a supervised exercise program for patients with MPN based on longitudinal assessment of symptom burden, QoL, and clinical\/inflammatory markers (C-reactive protein, erythrocyte sedimentation rate, ferritin, lactate dehydrogenase [LDH], and serum cytokines). Patients with MPN (n = 55) were randomized 3:2 to a 12-week home-based exercise intervention (flexibility\/resistance\/aerobics) supervised by a kinesiologist vs waitlist control. Measures included patient-reported outcome questionnaires, peripheral blood sampling, and postintervention interviews with participants. Forty-seven patients completed the trial (FIT group, n = 26; control group, n = 21). Median age was 66 years (range, 27-86), and 60% were female. All feasibility benchmarks were met, with 88% of participants satisfied and 92% with intent to continue an exercise program on a regular basis. A significant reduction in LDH was observed in FIT patients compared with controls (\u221214.5 U\/L vs +4.0 U\/L; P = .03). Patients interviewed described positive effects of the intervention on symptoms and would unanimously recommend the program to others with MPN. In this pilot study, supervised exercise was feasible, acceptable, and showed potential benefits on inflammatory\/disease markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018682","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T21:23:52Z","timestamp":1767821032000},"page":"2142-2152","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1888-8190","authenticated-orcid":false,"given":"Marie","family":"Ouellet","sequence":"first","affiliation":[{"name":"1Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada"},{"name":"2Department of Medicine, University of Montreal, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-7361","authenticated-orcid":false,"given":"Angelo","family":"Rizzolo","sequence":"additional","affiliation":[{"name":"3Segal Cancer Centre, Jewish General Hospital, Montreal, Canada"},{"name":"4Department of Medicine, McGill University, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Venne","sequence":"additional","affiliation":[{"name":"5Quebec Kinesiologist Federation, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"Moussa","sequence":"additional","affiliation":[{"name":"6Quebec CML-MPN Research Group, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Bilodeau","sequence":"additional","affiliation":[{"name":"7Faculty of Nursing, University of Montreal, Montreal, Canada"},{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigina","family":"Mollica","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada"},{"name":"2Department of Medicine, University of Montreal, Montreal, Canada"},{"name":"6Quebec CML-MPN Research Group, Montreal, Canada"},{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Chabot-Roy","sequence":"additional","affiliation":[{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Huynh-Trudeau","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada"},{"name":"2Department of Medicine, University of Montreal, Montreal, Canada"},{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-2795","authenticated-orcid":false,"given":"Sylvie","family":"Lesage","sequence":"additional","affiliation":[{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"},{"name":"9D\u00e9partement de microbiologie, infectiologie et immunologie, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Harnois","sequence":"additional","affiliation":[{"name":"6Quebec CML-MPN Research Group, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-3749","authenticated-orcid":false,"given":"Lambert","family":"Busque","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada"},{"name":"2Department of Medicine, University of Montreal, Montreal, Canada"},{"name":"6Quebec CML-MPN Research Group, Montreal, Canada"},{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Sirhan","sequence":"additional","affiliation":[{"name":"3Segal Cancer Centre, Jewish General Hospital, Montreal, Canada"},{"name":"4Department of Medicine, McGill University, Montreal, Canada"},{"name":"6Quebec CML-MPN Research Group, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-6171","authenticated-orcid":false,"given":"Natasha","family":"Szuber","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada"},{"name":"2Department of Medicine, University of Montreal, Montreal, Canada"},{"name":"6Quebec CML-MPN Research Group, Montreal, Canada"},{"name":"8Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"2","key":"2026041408023817500_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2011-01-328955","article-title":"The myeloproliferative neoplasm symptom assessment form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients","volume":"118","author":"Scherber","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2026041408023817500_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cncr.29753","article-title":"Comprehensively understanding fatigue in patients with myeloproliferative neoplasms","volume":"122","author":"Scherber","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"2026041408023817500_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.22365","article-title":"The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international internet-based survey of 1179 MPD patients","volume":"109","author":"Mesa","year":"2007","journal-title":"Cancer"},{"issue":"suppl 1","key":"2026041408023817500_bib4","first-page":"3453","article-title":"Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?","volume":"130","author":"Langlais","year":"2017","journal-title":"Blood"},{"issue":"33","key":"2026041408023817500_bib5","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","article-title":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs","volume":"30","author":"Emanuel","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"2026041408023817500_bib6","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3109\/10428194.2014.983098","article-title":"Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors","volume":"56","author":"Mesa","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"2026041408023817500_bib7","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.2174\/092986712803251511","article-title":"Biology and clinical management of myeloproliferative neoplasms and development of the JAK inhibitor ruxolitinib","volume":"19","author":"Mascarenhas","year":"2012","journal-title":"Curr Med Chem"},{"issue":"2","key":"2026041408023817500_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14740338.2021.1865912","article-title":"The safety of JAK kinase inhibitors for the treatment of myelofibrosis","volume":"20","author":"Coltro","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"2026041408023817500_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1200\/JCO.2015.62.9337","article-title":"Symptomatic profiles of patients with polycythemia vera: implications of inadequately controlled disease","volume":"34","author":"Geyer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026041408023817500_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41408-025-01234-8","article-title":"Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group","volume":"15","author":"Poullet","year":"2025","journal-title":"Blood Cancer J"},{"issue":"20","key":"2026041408023817500_bib11","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2014.57.6652","article-title":"Risk and cause of death in patients diagnosed with myeloproliferative neoplasms in Sweden between 1973 and 2005: a population-based study","volume":"33","author":"Hultcrantz","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026041408023817500_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2013.12.014","article-title":"Frequent participation in high volume exercise throughout life is associated with a more differentiated adaptive immune response","volume":"39","author":"Moro-Garc\u00eda","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2026041408023817500_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(99)00014-7","article-title":"Effects of 6 months of moderate aerobic exercise training on immune function in the elderly","volume":"109","author":"Woods","year":"1999","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"2026041408023817500_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11899-014-0227-0","article-title":"An immune dysregulation in MPN","volume":"9","author":"Barosi","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"2026041408023817500_bib15","first-page":"CD009075","article-title":"Aerobic physical exercise for adult patients with haematological malignancies","volume":"1","author":"Knips","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2026041408023817500_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/annonc\/mdt568","article-title":"Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy","volume":"25","author":"Streckmann","year":"2014","journal-title":"Ann Oncol"},{"issue":"27","key":"2026041408023817500_bib17","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1200\/JCO.2008.20.0634","article-title":"Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients","volume":"27","author":"Courneya","year":"2009","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026041408023817500_bib18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/healthcare12111101","article-title":"Pilot randomized controlled trial of Lymfit: a theory-guided exercise intervention for young adults with lymphoma","volume":"12","author":"Tock","year":"2024","journal-title":"Healthcare (Basel)"},{"issue":"10","key":"2026041408023817500_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2012.05.016","article-title":"A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy","volume":"36","author":"Alibhai","year":"2012","journal-title":"Leuk Res"},{"issue":"6","key":"2026041408023817500_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ejh.13048","article-title":"Associations between fatigue, physical activity, and QoL in patients with myeloproliferative neoplasms","volume":"100","author":"Tolstrup Larsen","year":"2018","journal-title":"Eur J Haematol"},{"issue":"24","key":"2026041408023817500_bib21","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1002\/cam4.3566","article-title":"The SIMM study: survey of integrative medicine in myeloproliferative neoplasms","volume":"9","author":"Gowin","year":"2020","journal-title":"Cancer Med"},{"issue":"5","key":"2026041408023817500_bib22","first-page":"e12865","article-title":"The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-an explorative study","volume":"27","author":"Pedersen","year":"2018","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"2026041408023817500_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12906-019-2530-8","article-title":"Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research","volume":"19","author":"Huberty","year":"2019","journal-title":"BMC Complement Altern Med"},{"issue":"10","key":"2026041408023817500_bib24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026041408023817500_bib25","unstructured":"Groupe Quebecois LMC-NMP\n          . Guidelines. Accessed 6 October 2025. https:\/\/www.gqr-lmc-nmp.ca\/chronic-myelogenous-leukemia-cml\/lmc-guides-therapeutiques\/?lang=en."},{"issue":"7","key":"2026041408023817500_bib26","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2026041408023817500_bib27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026041408023817500_bib28","first-page":"46","article-title":"The 2021 Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and electronic Physical Activity Readiness Medical Examination (ePARmed-X+)","volume":"16","author":"Warburton","year":"2023","journal-title":"Health Fit J Can"},{"key":"2026041408023817500_bib29","author":"Liguori","year":"2020","edition":"11th ed"},{"issue":"9","key":"2026041408023817500_bib30","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"2026041408023817500_bib31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/blood-2012-01-403279","article-title":"A prognostic model to predict survival in 867 World Health Organization\u2013defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment","volume":"120","author":"Passamonti","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2026041408023817500_bib32","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"issue":"13","key":"2026041408023817500_bib33","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"issue":"11","key":"2026041408023817500_bib34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: consensus statement from International Multidisciplinary Roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"2026041408023817500_bib35","author":"Borg","year":"1985"},{"issue":"5","key":"2026041408023817500_bib36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","article-title":"How we design feasibility studies","volume":"36","author":"Bowen","year":"2009","journal-title":"Am J Prev Med"},{"issue":"7","key":"2026041408023817500_bib37","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"issue":"11","key":"2026041408023817500_bib38","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s11136-016-1325-3","article-title":"Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study","volume":"25","author":"Quach","year":"2016","journal-title":"Qual Life Res"},{"issue":"18","key":"2026041408023817500_bib39","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1002\/cncr.26739","article-title":"Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors","volume":"118","author":"Baser","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"2026041408023817500_bib40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.urology.2004.04.056","article-title":"Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation","volume":"64","author":"Rosen","year":"2004","journal-title":"Urology"},{"issue":"5","key":"2026041408023817500_bib41","first-page":"2613","article-title":"Young adult cancer survivors' experience of taking part in a 12-week exercise referral programme: a qualitative study of the Trekstock RENEW initiative","volume":"29","author":"Below","year":"2021","journal-title":"Support Care Cancer"},{"issue":"1","key":"2026041408023817500_bib42","first-page":"e1655","article-title":"Disabled, invisible and dismissed-the lived experience of fatigue in people with myeloproliferative neoplasms","volume":"6","author":"Bradford","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"issue":"4","key":"2026041408023817500_bib43","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1177\/1534735418808595","article-title":"Perceptions of myeloproliferative neoplasm patients participating in an online yoga intervention: a qualitative study","volume":"17","author":"Huberty","year":"2018","journal-title":"Integr Cancer Ther"},{"key":"2026041408023817500_bib44","volume-title":"Qualitative Data Analysis: A Methods Sourcebook","author":"Miles","year":"2014","edition":"3rd Ed"},{"key":"2026041408023817500_bib45","author":"Patton","year":"2014","edition":"4th ed"},{"issue":"12","key":"2026041408023817500_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41408-017-0024-9","article-title":"Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates","volume":"7","author":"Shah","year":"2017","journal-title":"Blood Cancer J"},{"issue":"22","key":"2026041408023817500_bib47","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1182\/blood.V128.22.3120.3120","article-title":"The prognostic relevance of serum lactate dehydrogenase and mild reticulin fibrosis in essential thrombocythemia","volume":"128","author":"Mudireddy","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2026041408023817500_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1519\/JSC.0b013e31828f1ee9","article-title":"Exercise intensity and recovery: biomarkers of injury, inflammation, and oxidative stress","volume":"30","author":"Bessa","year":"2016","journal-title":"J Strength Cond Res"},{"issue":"22","key":"2026041408023817500_bib49","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.3390\/ijerph20227082","article-title":"Exercise-induced muscle damage after a high-intensity interval exercise session: systematic review","volume":"20","author":"Leite","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026041408023817500_bib50","doi-asserted-by":"crossref","first-page":"652023","DOI":"10.3389\/fphys.2021.652023","article-title":"Effect of chronic exercise training on blood lactate metabolism among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Physiol"},{"issue":"1","key":"2026041408023817500_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2005-837507","article-title":"Effects of training on lactate kinetics parameters and their influence on short high-intensity exercise performance","volume":"27","author":"Messonnier","year":"2006","journal-title":"Int J Sports Med"},{"key":"2026041408023817500_bib52","doi-asserted-by":"crossref","first-page":"1620723","DOI":"10.3389\/fgene.2025.1620723","article-title":"Aerobic exercise-induced lactate production: a novel opportunity for remodeling the tumor microenvironment","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Genet"},{"issue":"3","key":"2026041408023817500_bib53","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1097\/HS9.0000000000000407","article-title":"Cytokine profiling as a novel complementary tool to predict prognosis in MPNs?","volume":"4","author":"Hasselbalch","year":"2020","journal-title":"HemaSphere"},{"issue":"9","key":"2026041408023817500_bib54","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/cells9092136","article-title":"Cytokine profiling in myeloproliferative neoplasms: overview on phenotype correlation, outcome prediction, and role of genetic variants","volume":"9","author":"Masselli","year":"2020","journal-title":"Cells"},{"issue":"8","key":"2026041408023817500_bib55","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/bloodadvances.2019001317","article-title":"Impact of exercise on the immune system and outcomes in hematologic malignancies","volume":"4","author":"Sitlinger","year":"2020","journal-title":"Blood Adv"},{"key":"2026041408023817500_bib56","doi-asserted-by":"crossref","first-page":"1663560","DOI":"10.3389\/fimmu.2025.1663560","article-title":"Effects of different exercise prescription parameters on metabolic and inflammatory biomarkers in cancer patients: a systematic review, meta-analysis, and meta-regression","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"issue":"10","key":"2026041408023817500_bib57","doi-asserted-by":"crossref","first-page":"e0275782","DOI":"10.1371\/journal.pone.0275782","article-title":"The relationship between objective measures of physical function and serum lactate dehydrogenase in older adults with cancer prior to treatment","volume":"17","author":"Papadopoulos","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"2026041408023817500_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.mayocp.2018.08.022","article-title":"3023 Mayo Clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups","volume":"94","author":"Szuber","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"2026041408023817500_bib59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2020-137611","article-title":"A population-based study of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001-2015","volume":"136","author":"Smith","year":"2020","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2142\/2510657\/blooda_adv-2025-018682-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2142\/2510657\/blooda_adv-2025-018682-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:02:50Z","timestamp":1776168170000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2142\/565891\/MPN-FIT-a-randomized-controlled-pilot-trial-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018682","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,3,25]]}}}